Hot Alert : API Technologies Corp. (NASDAQ:ATNY), InvenSense, Inc. (NYSE:INVN), FireEye, Inc. (NASDAQ:FEYE), Onconova Therapeutics, Inc. (NASDAQ:ONTX), Google Inc (NASDAQ:GOOGL)

API Technologies Corp (NASDAQ:ATNY) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a research note issued on Wednesday. The firm currently has a $2.30 price target on the stock. Zacks‘s price objective suggests a potential upside of 2.22% from the stock’s previous close. API Technologies Corp. (NASDAQ:ATNY) belongs to Technology sector. Its net profit margin is -7.90% and weekly performance is -3.49%. On … Continue reading Hot Alert : API Technologies Corp. (NASDAQ:ATNY), InvenSense, Inc. (NYSE:INVN), FireEye, Inc. (NASDAQ:FEYE), Onconova Therapeutics, Inc. (NASDAQ:ONTX), Google Inc (NASDAQ:GOOGL)

Mark Doerr09/1509/15

Top Stories : Onconova Therapeutics (NASDAQ:ONTX), Comcast (NASDAQ:CMCSA), Salix Pharmaceuticals (NASDAQ:SLXP), Radio One Inc. (NASDAQ:ROIA), W&T Offshore (NYSE:WTI)

Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today provided a corporate update and reported financial results for the second quarter ended June 30, 2014. Onconova Therapeutics, Inc. (NASDAQ:ONTX) belongs to Healthcare sector. Its weekly performance is 5.50%. On last trading day company shares ended up $5.37. Onconova Therapeutics, Inc. (NASDAQ:ONTX) distance from 50-day simple … Continue reading Top Stories : Onconova Therapeutics (NASDAQ:ONTX), Comcast (NASDAQ:CMCSA), Salix Pharmaceuticals (NASDAQ:SLXP), Radio One Inc. (NASDAQ:ROIA), W&T Offshore (NYSE:WTI)

Mark Doerr08/1508/15

Biotech Gainers: Ignyta Inc (NASDAQ:RXDX), Onconova Therapeutics Inc (NASDAQ:ONTX), Cempra Inc (NASDAQ:CEMP), ANI Pharmaceuticals Inc (NASDAQ:ANIP)

Ignyta Inc (NASDAQ:RXDX) released its earnings data. The company reported ($0.28) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.37) by $0.09. Finally, analysts at Ladenburg Thalmann initiated coverage on shares of company in a research note on Monday, March 24th. They set a “buy” rating and a $20.00 price target on the stock. Ignyta Inc (NASDAQ:RXDX) stock performance was 13.12% … Continue reading Biotech Gainers: Ignyta Inc (NASDAQ:RXDX), Onconova Therapeutics Inc (NASDAQ:ONTX), Cempra Inc (NASDAQ:CEMP), ANI Pharmaceuticals Inc (NASDAQ:ANIP)

Chris Lewis05/3005/30

Biotech Stocks Touched New Lows: Onconova Therapeutics Inc (NASDAQ:ONTX), Array Biopharma (NASDAQ:ARRY), AVEO Pharmaceuticals (NASDAQ:AVEO), Infinity Pharmaceuticals (NASDAQ:INFI)

Onconova Therapeutics Inc (NASDAQ:ONTX)’s share price has entered into oversold territory with an RSI value of 19.3. The Zacks Consensus Estimate for Onconova Therapeutics Inc (NASDAQ:ONTX) for the full year period has improved 75 cents over the past two months to $-2.09 per share. Currently, Onconova Therapeutics Inc (NASDAQ:ONTX) has a Zacks Rank #2 (Buy), suggesting that now might be a good time to get … Continue reading Biotech Stocks Touched New Lows: Onconova Therapeutics Inc (NASDAQ:ONTX), Array Biopharma (NASDAQ:ARRY), AVEO Pharmaceuticals (NASDAQ:AVEO), Infinity Pharmaceuticals (NASDAQ:INFI)

Mark Doerr04/0704/07

Biotech New Lows: AVEO Pharmaceuticals (NASDAQ:AVEO), Onconova Therapeutics (NASDAQ:ONTX), BioTime (NYSEMKT:BTX), Tetralogic Pharmaceuticals (NASDAQ:TLOG)

FDA publicly (justifiably) took down AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) when patients on its drug survived less long than those in the control group. Novo Nordisk found itself years behind competitors because the FDA insists on a heart safety study of its new insulin. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) stock performance was -3.21% in last session and finished the day at $1.51. Traded volume was 730,784.00million shares … Continue reading Biotech New Lows: AVEO Pharmaceuticals (NASDAQ:AVEO), Onconova Therapeutics (NASDAQ:ONTX), BioTime (NYSEMKT:BTX), Tetralogic Pharmaceuticals (NASDAQ:TLOG)

Colin Pettis03/3103/31

Biotech New Lows: Galmed Pharmaceuticals (NASDAQ:GLMD), Recro Pharma (NASDAQ:REPH), BioTime (NYSEMKT:BTX), Onconova Therapeutics (NASDAQ:ONTX)

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) announced the closing of its initial public offering of 3,263,010 ordinary shares at a public offering price of $13.50 per share, which included 425,610 ordinary shares issued upon the exercise in full of the underwriters’ option to purchase additional ordinary shares to cover over-allotments. Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) stock performance was -1.58% in last session and finished the day at $10.93. … Continue reading Biotech New Lows: Galmed Pharmaceuticals (NASDAQ:GLMD), Recro Pharma (NASDAQ:REPH), BioTime (NYSEMKT:BTX), Onconova Therapeutics (NASDAQ:ONTX)

Jayne Crisman03/2803/28